Xeljanz Commercial 2024. Zydus lifesciences' subsidiary zydus pharmaceuticals (usa) inc. New york, september 1, 2021 — the u.s.
She works on her laptop and plays with her daughter. Rheumatoid arthritis (ra) patients 50 years of age and older with at least one additional cardiovascular (cv) risk factor treated with xeljanz 10 mg twice a day.